Not yet recruiting NCT07577427
Benign and Malignant Adrenal Gland Surgery: Single Center Experience
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Surgery with and without the aid of Indocyanine Green (ICG).
- Who it may be relevant to
- Registry conditions: Adrenal Gland Disease. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
PATIENTS AFFECTED BY ADRENAL GLAND DISEASE WITH SURGICAL INDICATION OF ROBOTIC OR LAPAROSCOPIC ADRENALECTOMY
Interventions
- Procedure Surgery with and without the aid of Indocyanine Green (ICG)
NO DIFFERENCES
Primary outcome measures
- POSTOPERATIVE COMPLICATIONS [Time frame: FROM ENROLLMENT TO THE END OF TREATMENT AT 5 YEARS]
Eligibility criteria
Inclusion criteria
- ADRENAL GLAND DISEASE
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- Policlinico Umberto I — Roma
Identifiers
NCT: NCT07577427 · 01162026/02 · 01162026/02